Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,519.12
(
0.61%
)
US TECH 100
29,169.20
(
1.63%
)
Dow Jones
50,461.68
(
-0.23%
)
Brent Oil
96.99
(
-4.14%
)
Bitcoin
75,800.02
(
-1.90%
)
News Focus
News Focus
Post# of 882
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 123024
Boards Moderated 9
Alias Born 09/05/2002

DewDiligence

Member Level

Re: DewDiligence post# 116

Sunday, 11/13/2011 11:28:53 AM

Sunday, November 13, 2011 11:28:53 AM

Post# of 882
ABT ‘ReadMeFirst’ updated:

info on Humira, Tofacitinib, and VX-509 from ACR;
FDA approves Xience Prime;
PRGO submits Androgel ANDA;
FDA requests phase-4 “outcomes” trial for TriLipix.

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=68938722

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent ABT News
More ABT News